IL6 and COVID-19: After stimulation with human rIL6, there was no significant increase in IL-1β, IL-6 or IFN-γ lymphocyte or monocyte producers, suggesting that human rIL-6 in COVID-19 patients may not induce the synthesis of proinflammatory cytokines by circulating leucocytes.